1. Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia

3. Introduction

4. Hospitalization Rate Meta-Analysis Long-Acting Injectables vs Oral Antipsychotic

5. Swedish Registry: Mortality Risk LAIs and Oral Antipsychotics

6. Recent Online Survey Persons With Lived Experience and Caretakers

7. Psychiatrists Attitudes Long-Acting Injectables

8. Real-World Data: PRELAPSE Trial

9. Real-World Data: PRELAPSE Trial Findings

10. LAI Antipsychotics Second-Generation Agents

11. Understanding Adverse Event History Expert Consensus Survey

12. LAI Antipsychotics First-Generation Dosing Overview

13. LAI Characteristics and Properties Prescribing Considerations

14. FDA-Approved LAIs for Schizophrenia Characteristics of First- and Second-Generation LAIs

15. Discussing LAI Options: Considering the Experience of the Person With Lived Experience and Their Family

16. LAI Selection Factors Expert Consensus Survey

17. Summary of Recommendations Expert Consensus Survey

18. Shared Decision Making

19. Patient Preference Discussion Considering an LAI

20. Multidisciplinary Team Needs to Be Aligned

21. Multidisciplinary Team Education

22. Concise Communication and Education

23. Use of LAIs Clinical Insights

24. Evolution of Opinions Who Are Candidates for LAI Antipsychotics?

25. Concluding Remarks

26. Lived Experience With Schizophrenia Q&A

27. Can you tell us what is the most difficult or frustrating aspect of managing your experience with schizophrenia?

28. Was there anything regarding treatment that was problematic and would be best to avoid?

29. What is it like to take medications for schizophrenia?

30. Can you talk about your experience with long acting, injectable medication?

31. What has been the most difficult aspect of treatment for you?

32. How did you get help with this aspect?

33. Was there anyone in particular on the team that was able to help?

34. How were they able to help? What did they do?

35. Other than medications, what did you find helpful?

36. What advice would you like to give to providers?

37. What is the best way to include family?

38. What is the best way to include members of the treatment team?

39. Abbreviations